Camilo Brandão-De-Resende

Camilo Brandão-De-Resende

Auto-generated profile, based on publicly available information

Camilo Brandão-De-Resende

Department of Ophthalmology and Otorhinolaryngology, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2019 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
TRT. Ris
T. Ris
ATA. Teixeira‐Carvalho
A. Teixeira‐Carvalho
RCR. Matos Pinto Coelho
R. Matos Pinto Coelho
CBC. Brandao‐De‐Resende
C. Brandao‐De‐Resende
MGM. Souza Gomes
M. Souza Gomes
MNMaria Carmo Pereira Nunes
Maria Carmo Pereira Nunes
Infective endocarditis (IE) is the cardiac disease with the highest rates of mortality. New biomarkers that are able to identify patients at risk for death are required to improve patient management and outcome. This study aims to investigate if cytokines, chemokines and growth factors measured at IE diagnosis can predict mortality. Patients with definite IE, according to the Duke’s modified criteria, were included. Using high‐performance Luminex assay, 27 different cytokines, chemokines and growth factors were analyzed. Machine learning techniques were used for the prediction of death and subsequently creating a decision tree, in which the cytokines, chemokines and growth factors were analyzed together with C‐reactive protein (CRP). Sixty‐nine patients were included, 41 (59%) male, median age 54 [interquartile range (IQR) = 41–65 years] and median time between onset of the symptoms and diagnosis was 12 days (IQR = 5–30 days). The in‐hospital mortality was 26% (n = 18). Proinflammatory cytokines interkeukin (IL)‐15 and C‐C motif chemokine ligand (CCL4) were found to predict death, adding value to CRP levels. The decision tree predicted correctly the outcome of 91% of the patients at hospital admission. The high‐risk group, defined as CRP ≥ 72 mg/dL, IL‐15 ≥ 5·6 fg/ml and CCL4 ≥ 6·35 fg/ml had an 88% in‐hospital mortality rate, whereas the patients classified as low‐risk had a mortality rate of 8% (P =  < 0·001). Cytokines IL‐15 and CCL4 were predictors of mortality in IE, adding prognostic value beyond that provided by CRP levels. Assessment of cytokines has potential value for clinical risk stratification and monitoring in IE patients.

2 December 2023 in eClinicalMedicine
Verified
Journal Article
Open access
CBCamilo Brandao-De-Resende
Camilo Brandao-De-Resende
MMMariane Melo
Mariane Melo
ELElsa Lee
Elsa Lee
AJAnish Jindal
Anish Jindal
YNYan N. Neo
Yan N. Neo
ADAlexander C. Day
Alexander C. Day
A substantial proportion of attendances to ophthalmic emergency departments are for non-urgent presentations. We developed and evaluated a machine learning system (DemDx Ophthalmology Triage System: DOTS) to optimise triage, with the aim of reducing inappropriate emergency attendances and streamlining case referral when necessary. DOTS was built using retrospective tabular data from 11,315 attendances between July 1st, 2021, to June 15th, 2022 at Moorfields Eye Hospital Emergency Department (MEH) in London, UK. Demographic and clinical features were used as inputs and a triage recommendation was given (“see immediately”, “see within a week”, or “see electively”). DOTS was validated temporally and compared with triage nurses’ performance (1269 attendances at MEH) and validated externally (761 attendances at the Federal University of Minas Gerais - UFMG, Brazil). It was also tested for biases and robustness to variations in disease incidences. All attendances from patients aged at least 18 years with at least one confirmed diagnosis were included in the study. For identifying ophthalmic emergency attendances, on temporal validation, DOTS had a sensitivity of 94.5% [95% CI 92.3–96.1] and a specificity of 42.4% [38.8–46.1]. For comparison within the same dataset, triage nurses had a sensitivity of 96.4% [94.5–97.7] and a specificity of 25.1% [22.0–28.5]. On external validation at UFMG, DOTS had a sensitivity of 95.2% [92.5–97.0] and a specificity of 32.2% [27.4–37.0]. In simulated scenarios with varying disease incidences, the sensitivity was ≥92.2% and the specificity was ≥36.8%. No differences in sensitivity were found in subgroups of index of multiple deprivation, but the specificity was higher for Q2 when compared to Q4 (Q4 is less deprived than Q2). At MEH, DOTS had similar sensitivity to triage nurses in determining attendance priority; however, with a specificity of 17.3% higher, DOTS resulted in lower rates of patients triaged to be seen immediately at emergency. DOTS showed consistent performance in temporal and external validation, in social-demographic subgroups and was robust to varying relative disease incidences. Further trials are necessary to validate these findings. This system will be prospectively evaluated, considering human-computer interaction, in a clinical trial. The Artificial Intelligence in Health and Care Award (AI_AWARD01671) of the NHS AI Lab under 10.13039/501100000272 National Institute for Health and Care Research (NIHR) and the Accelerated Access Collaborative (AAC).

11 March 2020 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
CBCamilo Brandão-De-Resende
Camilo Brandão-De-Resende
MBManohar Babu Balasundaram
Manohar Babu Balasundaram
SNShishir Narain
Shishir Narain
PMPadmamalini Mahendradas
Padmamalini Mahendradas
DVDaniel V. Vasconcelos-Santos
Daniel V. Vasconcelos-Santos
Multimodal imaging relies on combination of multiple imaging modalities to precisely delineate pathological changes in the posterior segment of the eye associated with a wide range of conditions. This combined application of fundus photography, optical coherence tomography, fundus reflectance/autofluorescence and fundus angiography (with fluorescein, indocyanine green and/or optical coherence tomography) is of great utility for assessment of patients with ocular toxoplasmosis. Multimodal imaging is helpful to characterize the typical pattern of toxoplasmic retinochoroiditis, with primary focal inflammatory involvement of the neurosensory retina, and secondary changes at the level of underlying choroid, retinal blood vessels, vitreous and even optic disc. It may also be valuable to document and follow local complications, including macular edema, vascular occlusions, and choroidal neovascularization, among others.

1 February 2017 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
JPJúlio R. Pimenta
Júlio R. Pimenta
AFAlexandre R. Ferreira
Alexandre R. Ferreira
EFEleonora D.T. Fagundes
Eleonora D.T. Fagundes
TQThaís C.N. Queiroz
Thaís C.N. Queiroz
RBRegiane A.N. Baptista
Regiane A.N. Baptista
FPFrancisco J. Penna
Francisco J. Penna

1 September 2019 in JAMA Ophthalmology
Verified
Journal Article
Open access
PDF file
CBCamilo Brandão-De-Resende
Camilo Brandão-De-Resende
LCLeandro H. M. Cunha
Leandro H. M. Cunha
SOSimone L. Oliveira
Simone L. Oliveira
LPLeonardo Pereira
Leonardo Pereira
JOJacqueline G. F. Oliveira
Jacqueline G. F. Oliveira
DVDaniel V. Vasconcelos-Santos
Daniel V. Vasconcelos-Santos
Yellow fever (YF) is caused by the YF virus, the prototype of the Flaviviridae family, comprising roughly 70 positive-sense, single-stranded RNA viruses that replicate in the cytoplasm of infected cells.1,2 Yellow fever is a zoonotic infection that is endemic in tropical areas of South America and Africa and is transmitted in a sylvatic cycle involving wild nonhuman primates and the mosquitoes of the genus Haemagogus in Americas and the genus Aedes in Africa.1,2 “Jungle yellow fever” infection occurs when humans are sporadically bitten by infected sylvatic mosquitoes.1 “Urban yellow fever” infection is the result of the transmission of the YF virus between humans, mainly by Aedes aegypti.1

1 December 2016 in Arquivos de Gastroenterologia
Verified
Journal Article
Open access
PDF file
JPJúlio Rocha Pimenta
Júlio Rocha Pimenta
AFAlexandre Rodrigues Ferreira
Alexandre Rodrigues Ferreira
PBPaulo Fernando Souto Bittencourt
Paulo Fernando Souto Bittencourt
CRCamilo Brandão de Resende
Camilo Brandão de Resende
EFEleonora Druve Tavares Fagundes
Eleonora Druve Tavares Fagundes
ISIsabela Maria Lopes da Silva
Isabela Maria Lopes da Silva
HEADINGS Liver cirrhosis; Esophageal and gastric varices, therapy; Disease prevention; Propranolol; Gastrointestinal endoscopy, rehabilitation; Child; Adolescent